L422-0829 Screening compound: 5-{[4-(3-chlorobenzamido)phenoxy]methyl}-N-[3-(morpholin-4-yl)propyl]-1,2-oxazole-3-carboxamide

L422-0829 Screening compound: 5-{[4-(3-chlorobenzamido)phenoxy]methyl}-N-[3-(morpholin-4-yl)propyl]-1,2-oxazole-3-carboxamide
L422-0829 Screening compound: 5-{[4-(3-chlorobenzamido)phenoxy]methyl}-N-[3-(morpholin-4-yl)propyl]-1,2-oxazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L422-0829
5-{[4-(3-chlorobenzamido)phenoxy]methyl}-N-[3-(morpholin-4-yl)propyl]-1,2-oxazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L422-0829

Molecular Formula

C25H27ClN4O5 (C25 H27 ClN4 O5)

Compound Name

5-{[4-(3-chlorobenzamido)phenoxy]methyl}-N-[3-(morpholin-4-yl)propyl]-1,2-oxazole-3-carboxamide

IUPAC name

5-{[4-(3-chlorobenzamido)phenoxy]methyl}-N-[3-(morpholin-4-yl)propyl]-12-oxazole-3-carboxamide

SMILES

O=C(c1noc(COc(cc2)ccc2NC(c2cccc(Cl)c2)=O)c1)NCCCN1CCOCC1

InChI

InChI=1S/C25H27ClN4O5/c26-19-4-1-3-18(15-19)24(31)28-20-5-7-21(8-6-20)34-17-22-16-23(29-35-22)25(32)27-9-2-10-30-11-13-33-14-12-30/h1,3-8,15-16H,2,9-14,17H2,(H,27,32)(H,28,31)

InChI Key

HZBWMHRCIYTJDY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27251828

Chemical and Physical Properties

Saltdata

CF3COOH

Molecular Weight

498.97

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.148

Distribution Coefficient, logD

2.760

Water Solubility, LogSw

-3.72

Polar Surface Area

87.680

Acid Dissociation Constant (pKa)

9.99

Base Dissociation Constant (pKb)

7.56

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

L422-0829 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with L422-0829 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L422-0829?
Check Price and Availability of L422-0829, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L422-0829 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L422-0829
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L422-0829
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L422-0829 available by request